Pharmafile Logo
Pharmafocus logo
Advanced Search
british_parliament_14749841802

UK secures early access to 90 million doses of coronavirus vaccines

July 20, 2020
Sales and Marketing COVID-19, coronaviurs, vaccines

The UK has secured early access to 90 million doses of coronavirus vaccines through multiple partnerships with pharmaceutical companies.

News

Innate Pharma announces new Executive Vice President and Chief Medical Officer

July 17, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Innate Pharma, appointment

Innate Pharma has named Dr Joyson Karakunnel as its new Executive Vice President and Chief Medical Officer (CMO), with current …

Appointment
astrazeneca_sign_sky

AstraZeneca secures accelerated FDA review for Farxiga for for CV death following heart attacks

July 17, 2020
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, FDA, farxiga, fast track

AstraZeneca has made it known that Farxiga (dapagliflozin) has secured Fast Track Designation from the FDA for the reduction of …

News
800px-smallpox_vaccine

WHO reports “alarming decline” in child vaccinations due to COVID-19 disruption

July 17, 2020
Medical Communications, Sales and Marketing COVID-19, WHO, vaccination, vaccines

The World Health Organization and UNICEF have pointed to an “alarming decline” in the levels of children worldwide receiving essential …

News
fda

FDA grants fast review for Bayer and MSD’s heart failure drug vericiguat

July 17, 2020
Medical Communications Bayer, FDA, MSD

The FDA has granted a fast Priority Review for Bayer and MSD’s heart failure drug vericiguat. This was based on …

News
remsssy

Hydroxychloroquine proves ineffective against COVID-19 in newest trial

July 17, 2020
Medical Communications COVID-19, coronavirus, hydroxychloroquine

The newest clinical trial into hydroxychloroquine has proved unsuccessful in treating coronavirus patients. A recent study was published in the …

News
top_10_image_2_3

Top Ten most popular articles on Pharmafile.com this week

July 17, 2020
Medical Communications top 10

The news this week as usual centres on treatments and vaccines for COVID-19, with Russia claiming it is the first …

News
Doctor online

COVID-19 is pushing healthcare firms to embrace digital transformation, reports suggest

July 16, 2020
Medical Communications, Research and Development digital, healthcare, pharma

The COVID-19 pandemic forced industries across the board to evolve or die with regard to their approach to digital working …

News
az

AstraZeneca’s Brilinta reduces the rate of stroke and death in patients with acute ischaemic stroke or transient ischaemic attack

July 16, 2020
Business Services AZ, AstraZeneca, drug trials

AstraZeneca’s Phase 3 THALES trial showed that Brilinta (ticagrelor) significantly reduced the rate of death or stroke in patients with …

News

Novartis to provide ‘no-profit’ generics to low income countries to help combat COVID-19

July 16, 2020
Business Services COVID-19, Novartis, coronavirus, hydroxychloroquine

The Sandoz division of Novartis will not make a profit on the 15 generics it is making available to developing …

News

Trump administration orders hospitals to stop sending COVID-19 data to the CDC

July 16, 2020
Business Services CDC, COVID, coronavirus

The Trump administration has ordered hospitals to stop sending coronavirus patient data to the Centers for Disease Control and Prevention …

News

Gilteritinib becomes first NICE-approved oral therapy for relapsed or refractory acute myeloid leukaemia

July 16, 2020
Sales and Marketing Atellas, NICE, UK, acute myeloid leukaemia, gilteritinib

NICE has revealed its recommendation of Astellas’ gilteritinib for routine use as a monotherapy on the NHS in England and …

News
janssen_latest_logo_on_sign

Jannsen’s Tremfya becomes first FDA-approved IL-23 inhibitor for active psoriatic arthritis

July 15, 2020
Research and Development, Sales and Marketing FDA, Jannsen, Tremfya, active psoriatic arthritis

Janssen has reported that its therapy Tremfya (guselkumab) has become the first selective interleukin (IL)-23 inhibitor approved by the FDA …

News
xockdown

UK lockdown caused infection ‘R’ rate to drop as low as 0.57, according to a new study

July 15, 2020
Research and Development COVID, COVID-19, Lockdown, coronavirus

A new study showed that the coronavirus infection rate hit its lowest point one month before lockdown restrictions were lifted. …

News
fdaoutsideweb

FDA committee backs GSK’s belantamab mafodotin in relapsed or refractory multiple myeloma

July 15, 2020
Research and Development, Sales and Marketing Cancer, FDA, GSK, multiple myeloma, pharma

The FDA’s Oncologic Drugs Advisory Committee (ODAC) has moved to recommend the use of GlaxoSmithKline’s belantamab mafodotin, or GSK2857916 as …

News
vaxx

Moderna’s COVID-19 vaccine candidate set for final testing in the US

July 15, 2020
Research and Development COVID-19, coronavirus

The first COVID-19 vaccine being used in clinical trials in the US is set to begin final testing. The experimental …

News
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

July 15, 2020
Research and Development COVID-19, coronavirus, vaccines

The coronavirus news this week focuses on therapeutics, with Gilead’s remdesivir reducing the risk of death in 62% of severe …

News
masksss

People in England must wear face mask in shops from 24 July

July 14, 2020
Manufacturing and Production coronavirus, masks

Face masks are set to become mandatory in shops across England beginning on 24 July, following months of mixed messaging …

News
shutter

Malaria prophylactic tafenoquine shows antiviral activity against SARS-CoV-2 in cell cultures

July 14, 2020
Manufacturing and Production, Research and Development 60 Degrees Pharmaceuticals, COVID-19, coronavirus, pharma

Specialist tropical disease drug firm 60 Degrees Pharmaceuticals has revealed that its therapy Arakoda (tafenoquine) has been shown in cell …

News
trialllllssss

Arthritis drug reduces COVID-19 deaths for patients on ventilators

July 14, 2020
Manufacturing and Production COVID-19, coronavirus

The rheumatoid arthritis drug tocilizumab reduces death rates in coronavirus patients on ventilation, according to new studies. 

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025